Correlation Between Bristol Myers and Revvity
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Revvity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Revvity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Revvity, you can compare the effects of market volatilities on Bristol Myers and Revvity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Revvity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Revvity.
Diversification Opportunities for Bristol Myers and Revvity
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between Bristol and Revvity is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Revvity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revvity and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Revvity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revvity has no effect on the direction of Bristol Myers i.e., Bristol Myers and Revvity go up and down completely randomly.
Pair Corralation between Bristol Myers and Revvity
Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.79 times more return on investment than Revvity. However, Bristol Myers Squibb is 1.26 times less risky than Revvity. It trades about 0.07 of its potential returns per unit of risk. Revvity is currently generating about -0.03 per unit of risk. If you would invest 5,545 in Bristol Myers Squibb on December 29, 2024 and sell it today you would earn a total of 345.00 from holding Bristol Myers Squibb or generate 6.22% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Bristol Myers Squibb vs. Revvity
Performance |
Timeline |
Bristol Myers Squibb |
Revvity |
Bristol Myers and Revvity Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bristol Myers and Revvity
The main advantage of trading using opposite Bristol Myers and Revvity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Revvity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revvity will offset losses from the drop in Revvity's long position.Bristol Myers vs. AbbVie Inc | Bristol Myers vs. Merck Company | Bristol Myers vs. Gilead Sciences | Bristol Myers vs. Johnson Johnson |
Revvity vs. Waters | Revvity vs. IDEXX Laboratories | Revvity vs. IQVIA Holdings | Revvity vs. Charles River Laboratories |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |